Default company panoramic image

Cellular Engineering Technologies

CET is a biopharmaceutical company whose mission is to develop diagnostic and therapeutic products and services in precision medicine.

  • Stage Full Product Ready
  • Industry Biotechnology
  • Location Iowa City, IA, US
  • Currency USD
  • Founded January 2005
  • Employees 10
  • Incorporation Type S-corp
  • Website

Company Summary

CET is a contract manufacturer and contract research service provider in regenerative medicine co-founded by Dr. Alan Moy. CET focusing on precision medicine and regenerative medicine applications through the manufacturing of human stem cells. CET's core competency allows it to target the following market segments: life science, CRO, bioprocessing, regenerative medicine and bio banking.


  • Default avatar
    Alan Moy M.D.

    Dr. Moy has over 20 years of success as a clinician, academician, entrepreneur and scientist. He is board certified in Internal Medicine and Pulmonary Medicine. He previously was on faculty member at the University of Iowa College of Medicine and College of Engineering and has expertise in the area of vascular biology, tissue engineering and industrial stem cell biology. Dr. Moy is a Leading Physicians of the World by the IHAP.

  • Default avatar
    Anant Kamath M.S., J.D.

    Mr. Kamath received his B.A. and B.S.C. degrees in Biochemistry from the University of Iowa. He is credited with developing CET’s stem cell technology. He received an M.S. in Microbiology from the Johns Hopkins University School of Public Health. Mr. He received a Juris Doctorate from the University of Iowa. He is a member in good standing of the Iowa State Bar Association, with expertise in patent law, Copyrights and corporate law.

  • Default avatar
    Anthony English Ph.D.
    VP of Bioinformation Technology

    Dr. English received a B.S. degree in Engineering and Physics from Simon Fraser University, an M.S. degree in Electrical and Biomedical Engineering from the University of Toronto, and a Ph.D. degree from MIT. He completed a postdoctoral fellowship at MIT. He served on faculty in the Department of Biomedical Engineering at the University of Iowa, the University of Tennessee and Western New England University. His area of expertise includes cellula


  • Default avatar
    Michael Pugh - Bradley and Riley
    Default avatar
    Carlson Hartsock and Guither

Previous Investors

  • Default avatar
    Alan Moy MD, Lloyda Moy, James Moy MD, Nina Fertey
    Default avatar
    Kim Lehman, Randy Lehman, Theresa Dowd, Brian Dowd
    Default avatar
    Bill Carmazzi, Anant Kamath